Literature DB >> 9456223

What should we expect from a bioartificial liver in fulminant hepatic failure?

H Bismuth1, J Figueiro, D Samuel.   

Abstract

Fulminant hepatic failure is associated with high mortality. Liver transplantation is an effective therapy that improves survival, and because of donor organ shortage and urgency, a bioartificial liver could act as an effective bridge to liver transplantation in patients with fulminant hepatic failure. We discuss the place of the bioartificial liver in the treatment of other causes of liver failure.

Entities:  

Mesh:

Year:  1998        PMID: 9456223     DOI: 10.1046/j.1525-1594.1998.06059.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  4 in total

1.  Liver transplantation and artificial liver support in fulminant hepatic failure.

Authors:  X F Zhu; G H Chen; X S He; M Q Lu; G D Wang; C J Cai; Y Yang; J F Huang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience.

Authors:  Cataldo Doria; Lucio Mandalá; Victor L Scott; Salvatore Gruttadauria; Ignazio R Marino
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Experimental study of bioartificial liver with cultured human liver cells.

Authors:  Ying-Jie Wang; Meng-Dong Li; Yu-Ming Wang; Qing-He Nie; Guo-Zheng Chen
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

4.  Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system.

Authors:  Hai-Hui Wang; Ying-Jie Wang; Hong-Ling Liu; Jun Liu; Yan-Ping Huang; Hai-Tao Guo; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.